Testing effectiveness (Phase 2)Study completedNCT00346892
What this trial is testing
To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV
Who this might be right for
Rotavirus Infections
GlaxoSmithKline 450